Wendy Burke

First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014

Bristi Basu, Emma Dean, M. Puglisi et al. · Clinical Cancer Research · 2015 · 126 citations

Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma

Aung Naing, Carol Aghajanian, Éric Raymond et al. · British Journal of Cancer · 2012 · 126 citations · Full text

A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours

Omar Khan, Martin Gore, Paul Lorigan et al. · British Journal of Cancer · 2011 · 125 citations · Full text

An Investigation into the Utility of a Multi-compartmental, Dynamic, System of the Upper Gastrointestinal Tract to Support Formulation Development and Establish Bioequivalence of Poorly Soluble Drugs

Paul A. Dickinson, Ragheb Abu Rmaileh, L. J. Ashworth et al. · The AAPS Journal · 2012 · 105 citations · Full text

Support Formulation Development, Upper Gastrointestinal Tract, Physiology +7

A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer

Thomas Powles, Matthew Wheater, Omar Din et al. · European Urology · 2015 · 97 citations

Urology, Genitourinary Cancer, Medicine +5